Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC29A1 | Q99808 | 19/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | PDE2A | O00408 | 1/20 | 0.40 |
| ▸ | RGS12 | O14924 | 1/20 | 0.40 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.40 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.40 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.40 |
| ▸ | ABCC5 | O15440 | 1/20 | 0.40 |
| ▸ | PDE6D | O43924 | 1/20 | 0.40 |
| ▸ | PDE8A | O60658 | 1/20 | 0.40 |
| ▸ | GMNN | O75496 | 1/20 | 0.40 |
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
| ▸ | PDE5A | O76074 | 1/20 | 0.40 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.40 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.40 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3301414 | 0.93 | SLC29A1 (0.51) | SLC29A1MEN1LMNAGAAMAPT | |
| SCHEMBL2219150 | 0.88 | SLC29A1 (0.49) | SLC29A1MEN1GAAKMT2A | |
| SCHEMBL1032559 | 0.88 | SLC29A1 (0.49) | SLC29A1MEN1GAAKMT2A | |
| SCHEMBL14715387 | 0.84 | SLC29A1 (0.60) | SLC29A1KDM4EMEN1ALDH1A1LMNA | |
| SCHEMBL14159189 | 0.81 | SLC29A1 (0.46) | SLC29A1KDM4EMEN1PDE2ARGS12 | |
| SCHEMBL10454781 | 0.80 | CA1 (0.38) | SLC29A1KDM4EMEN1ALDH1A1LMNA | |
| SCHEMBL2834273 | 0.80 | SLC29A1 (0.53) | SLC29A1KDM4EMEN1PDE2ARGS12 | |
| SCHEMBL1031350 | 0.80 | KMT2A (0.50) | SLC29A1MEN1GAACYP2D6CYP2C19 | |
| SCHEMBL1033545 | 0.80 | KMT2A (0.50) | SLC29A1KDM4EMEN1ALDH1A1GAA | |
| SCHEMBL1032941 | 0.80 | SLC29A1 (0.53) | SLC29A1KDM4EMEN1PDE2ARGS12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010066686-A2 | NOVEL TRIAZINE POLYMERS, METHOD FOR THE PRODUCTION AND USE THEREOF | BOREALIS AGROLINZ MELAMINE GMBH (AT) | 2010-06-17 | — | — | WO | claimed |
| EP-0390278-A1 | 3-(1,3-oxazolidinyl)-s-triazine | DSM N.V. (NL) | 1990-10-03 | — | — | EP | claimed |
| EP-2268610-B1 | METHOD FOR PRODUCING A COMPOUND WITH AT LEAST ONE AT LEAST MONOSUBSTITUTED AMINO GROUP | BOREALIS AGROLINZ MELAMINE (AT) | 2016-08-03 | — | — | EP | disclosed |
| US-8871842-B2 | Method for producing a compound with at least one at least monosubstituted amino group | BOREALIS AGROLINZ MELAMINE GMBH (AT) | 2014-10-28 | — | — | US | disclosed |
| EP-2774922-A1 | Method for obtaining a functionalized triazine compound and the triazine compound obtained by said method | Borealis Agrolinz Melamine GmbH (AT) | 2014-09-10 | — | — | EP | disclosed |
| US-20110178212-A1 | Method for Producing a Compound with at Least One at Least Monosubstituted Amino Group | BOREALIS AGROLINZ MELAMINE GMBH (AT) | 2011-07-21 | — | — | US | disclosed |
| EP-2268610-A1 | METHOD FOR PRODUCING A COMPOUND WITH AT LEAST ONE AT LEAST MONOSUBSTITUTED AMINO GROUP | Borealis Agrolinz Melamine GmbH (AT) | 2011-01-05 | — | — | EP | disclosed |
| WO-2010066686-A2 | NOVEL TRIAZINE POLYMERS, METHOD FOR THE PRODUCTION AND USE THEREOF | BOREALIS AGROLINZ MELAMINE GMBH (AT) | 2010-06-17 | — | — | WO | disclosed |
| WO-2009121603-A1 | METHOD FOR PRODUCING A COMPOUND WITH AT LEAST ONE AT LEAST MONOSUBSTITUTED AMINO GROUP | BOREALIS AGROLINZ MELAMINE GMBH (AT) | 2009-10-08 | — | — | WO | disclosed |
| US-20040054083-A1 | Coating with volatile-free aminoplast crosslinker | BASF CORPORATION (US) | 2004-03-18 | — | — | US | disclosed |
| WO-2001044333-A1 | THERMOSETTING RESIN OBTAINED BY REACTION OF A TRIAZINE COMPOUND WITH AN ALDEHYDE AND AN ACTIVATED OLEFINIC COMPOUND | DSM N.V. (NL) | 2001-06-21 | — | — | WO | disclosed |
| US-5536795-A | ADHESIVES AND PAINTS AND FIREPROOFING THERMOSETTING RESINS | MITSUI TOATSU CHEMICALS, INC. (JP) | 1996-07-16 | — | — | US | disclosed |
| US-5480947-A | N-METHYLOL DIGUANAMINES | MITSUI TOATSU CHEMICALS, INC. (JP) | 1996-01-02 | — | — | US | disclosed |
| EP-0612797-A2 | Modification method of resins | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1994-08-31 | — | — | EP | disclosed |
| EP-0390278-A1 | 3-(1,3-oxazolidinyl)-s-triazine | DSM N.V. (NL) | 1990-10-03 | — | — | EP | disclosed |
| EP-0166297-B1 | PROCESS FOR THE PREPARATION OF (2-HYDROXYETHYL)MELAMINES | BASF Aktiengesellschaft (DE) | 1988-08-31 | — | — | EP | disclosed |
| EP-0225433-A2 | Hydroxyoxaalkyl melamines, process for their preparation and their use | BASF Aktiengesellschaft (DE) | 1987-06-16 | — | — | EP | disclosed |
| US-4668785-A | FROM MELAMINE AND ETHANOLAMINE, ACID CATALYST | BASF AKTIENGESELLSCHAFT (DE) | 1987-05-26 | — | — | US | disclosed |
| EP-0221330-A1 | Foams and fibres made of melamine resins having an increased rigidity | BASF Aktiengesellschaft (DE) | 1987-05-13 | — | — | EP | disclosed |
| EP-0166297-A1 | Process for the preparation of (2-hydroxyethyl)melamines | BASF Aktiengesellschaft (DE) | 1986-01-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110178212-A1 | Method for Producing a Compound with at Least One at Least Monosubstituted Amino Group | INMT, AADAT, AANAT | SLC29A1 1070/4885KDM4E 1856/4885MEN1 380/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.